Home
Finance
Bank Routing Numbers
FedWire
Stock Portfolio Generator
Technical Analysis of Stocks
Best Months to Buy or Sell Stocks
Games
Hangman - Hang 'Em High
Chess
Shuttles Game
Chemistry
Chemical Equation Balancer
Periodic Table of the Elements
Chemical Bond Polarity Calculator
Linear Algebra
Gauss-Jordan Elimination Calculator
Calculate Pivots
Factorize: A=LU
Inverse Matrix Calculator
Null Space Calculator
Column Space Calculator
Row Space Calculator
Multiply Two Matrices
AI
Genetic Algorithms
Genetic Algorithms Stock Portfolio Generator
Shuttles Game
Tic-Tac-Toe Game
Personality Profile
Checkers Game
Scripts
Scan for all machines running IIS in a domain
Extract data from a Microsoft Word document
Outlook Scripts
Excel Scripts
IT
How to Stop a DDOS Attack
Subnet Calculator
Fingerprint Web Server
Whois Lookup
InternetPeriscope
About
My Favorite Links
Resume
View My Profile on LinkedIn
View My Profile on DataCamp
View My Profile on Pluralsight
Back to Companies who have applied for FDA Drug Approval
FDA Drug Approval Applications Sponsored by TRIS PHARMA INC
Application Number
Drugs/Products
Application Type
Most Recent Label Available Flag
Current Patent Flag
Action Type
Chemical Type
Ther Potential
Orphan Code
022499
CLONIDINE
New Drug Application
Approval
New formulation
(S) Standard review drug
022500
CLONIDINE
New Drug Application
Approval
New formulation
(S) Standard review drug
022556
KARBINAL ER
New Drug Application
Approval
New formulation
(S) Standard review drug
079058
IBUPROFEN
Abbreviated New Drug Application
Approval
079059
RISPERIDONE
Abbreviated New Drug Application
Approval
090461
LEVETIRACETAM
Abbreviated New Drug Application
Approval
090572
CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY
CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF
Abbreviated New Drug Application
Approval
091135
DEXTROMETHORPHAN POLISTIREX
Abbreviated New Drug Application
Approval
091286
GABAPENTIN
Abbreviated New Drug Application
Approval
091586
THEOPHYLLINE
Abbreviated New Drug Application
Approval
091601
METHYLPHENIDATE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
091632
HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX
Abbreviated New Drug Application
Approval
091675
PROMETHAZINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
091687
PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE
PROMETHAZINE HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
Abbreviated New Drug Application
Approval
200386
PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE
Abbreviated New Drug Application
Approval
201944
POTASSIUM CHLORIDE
Abbreviated New Drug Application
Approval
202214
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
Abbreviated New Drug Application
Approval
203518
MORPHINE SULFATE
Abbreviated New Drug Application
Approval
203519
MORPHINE SULFATE
Abbreviated New Drug Application
Approval
203644
DEXTROAMPHETAMINE SULFATE
Abbreviated New Drug Application
Approval
203838
HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
203839
HYDROCODONE BITARTRATE AND PSEUDOEPHEDRINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
206438
HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE
Abbreviated New Drug Application
Approval
207901
DEXMETHYLPHENIDATE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
208147
DYANAVEL XR
New Drug Application
Approval
New formulation
(S) Standard review drug
Back to Companies who have applied for FDA Drug Approval